- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jubilant Ingrevia Ltd (JUBN)
Jubilant Ingrevia Ltd stock price live, this page displays NSE JUBN stock exchange data. View the JUBN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jubilant Ingrevia Ltd real time stock price chart below.
What Is the Jubilant Ingrevia Ltd Stock Price Today?
The Jubilant Ingrevia Ltd stock price today is 599.85.
What Is the Stock Symbol for Jubilant Ingrevia Ltd?
The stock symbol for Jubilant Ingrevia Ltd is "JUBN."
What Stock Exchange Does Jubilant Ingrevia Ltd Trade On?
Jubilant Ingrevia Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Ingrevia Ltd a Good Stock to Buy?
Determining whether Jubilant Ingrevia Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBN quote. (ISIN: INE0BY001018)
What Is the Jubilant Ingrevia Ltd Stock Price Today?
The Jubilant Ingrevia Ltd stock price today is 599.85.
What Is the Stock Symbol for Jubilant Ingrevia Ltd?
The stock symbol for Jubilant Ingrevia Ltd is "JUBN."
What Stock Exchange Does Jubilant Ingrevia Ltd Trade On?
Jubilant Ingrevia Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Ingrevia Ltd a Good Stock to Buy?
Determining whether Jubilant Ingrevia Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBN quote. (ISIN: INE0BY001018)
599.85
+0.45(+0.08%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
597.10
614.90
52 wk Range
537.30
795.00
JUBLINGREA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
597.10614.90
52 wk Range
537.30795.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JUBLINGREA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
905.00
Upside
+50.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 905.00
(+50.87% Upside)
Jubilant Ingrevia Ltd Earnings Call Summary for Q2/2027
- Jubilant Ingrevia Q2 FY2027 revenue rose 24% YoY to INR 1,394 crore; EBITDA surged 51% to INR 221 crore, highest in three years.
- Company maintained full-year EBITDA guidance at INR 750-800 crore, expects results near upper end of range driven by all segments.
- Acquired 40% stake in ZettaOne Technologies for INR 189 crore, entering electronics and semiconductor manufacturing services market.
- CDMO pipeline holds 25+ confirmed molecules with INR 1,500+ crore peak revenue potential; one-third expected to convert in FY2027.
- Risks include vitamin B3 pricing pressure, lumpy CDMO revenue, delayed European competitor closure benefits, and elevated CapEx of INR 400-500 crore.
Last Updated: 2026-10-27, 08:22 a/m
Read Full TranscriptEarnings
Latest Release
Oct 27, 2026
EPS / Forecast
7.10 / 4.50
Revenue / Forecast
13.94B / 13.27B
Compare JUBLINGREA to Peers and Sector
Metrics to compare | JUBLINGREA | Peers Peers - average of corresponding metrics from companies closely matching JUBLINGREA: DEEPAKNTR, LXCHEM, SRF, VINATIORGA, ALKYLAMINE | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipJUBLINGREAPeersSector |
|---|---|---|---|---|
P/E Ratio | 27.0x | 29.6x | 3.9x | |
PEG Ratio | 1.27 | 0.31 | 0.00 | |
Price/Book | 2.9x | 2.7x | 1.6x | |
Price / LTM Sales | 1.9x | 2.2x | 1.2x | |
Upside (Analyst Target) | 50.9% | 11.9% | 49.2% | |
Fair Value Upside | Unlock | 16.1% | 5.5% | Unlock |
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments, Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol, such as acetic anhydride, bio acetic acid, bio-acetaldehyde, ethyl acetate, propionic anhydride, and formaldehyde. The company also provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, personal care, semiconductor, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Jubilant Ingrevia (JUBLINGREA) Stock Price Today?
The Jubilant Ingrevia stock price today is 599.85 INR.
What Stock Exchange Does Jubilant Ingrevia Trade On?
Jubilant Ingrevia is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Jubilant Ingrevia?
The stock symbol for Jubilant Ingrevia is "JUBLINGREA."
Does Jubilant Ingrevia Pay Dividends? What’s The Current Dividend Yield?
The Jubilant Ingrevia dividend yield is 0.8%%.
What Is the Jubilant Ingrevia Market Cap?
As of today, Jubilant Ingrevia market cap is 94.61B INR.
What Is Jubilant Ingrevia's Earnings Per Share (TTM)?
The Jubilant Ingrevia EPS (TTM) is 22.20.
When Is the Next Jubilant Ingrevia Earnings Date?
Jubilant Ingrevia will release its next earnings report on Feb 02, 2027.
From a Technical Analysis Perspective, Is JUBLINGREA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Jubilant Ingrevia Stock Split?
Jubilant Ingrevia has split 0 times.
How Many Employees Does Jubilant Ingrevia Have?
Jubilant Ingrevia has 2185 employees.
What is the current trading status of Jubilant Ingrevia (JUBLINGREA)?
As of Nov 13, 2026, Jubilant Ingrevia (JUBLINGREA) is trading at a price of 599.85 INR, with a previous close of 599.85 INR. The stock has fluctuated within a day range of 597.10 INR to 614.90 INR, while its 52-week range spans from 537.30 INR to 795.00 INR.
What Is Jubilant Ingrevia (JUBLINGREA) Price Target According to Analysts?
The average 12-month price target for Jubilant Ingrevia is 905.00 INR, with a high estimate of 1200 INR and a low estimate of 649 INR. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +50.87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.